{"id":"W1990941062","doi":"10.2165/00063030-200822040-00005","title":"Anti-Adhesion Molecule Strategies for Crohn Disease","year":2008,"lang":"en","type":"review","venue":"BioDrugs","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Infliximab; Crohn's disease; Adalimumab; Medicine; Monoclonal antibody; Disease; Tumor necrosis factor alpha; Monoclonal antibody therapy; Inflammatory bowel disease; Immunology; Monoclonal; Certolizumab pegol; Antibody; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007782197,0.0005430697,0.0006743632,0.00009292139,0.0001652481,0.00007208381,0.0004292769,0.0003961135,0.0000207104],"category_scores_gemma":[0.00008078317,0.0004804119,0.0009471261,0.00008328376,0.0001340511,0.000006272237,0.0001502829,0.0001111724,0.0001079233],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003217967,"about_ca_system_score_gemma":0.001459296,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002213512,"about_ca_topic_score_gemma":0.000001475795,"domain_scores_codex":[0.9981248,0.0001073659,0.0004450233,0.0007276082,0.0001742363,0.0004209987],"domain_scores_gemma":[0.998539,0.00001699346,0.0002509001,0.0007902533,0.0001048051,0.0002981013],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008575069,0.0009131284,0.00009119441,0.08042689,0.001373254,0.004022689,0.00008684079,0.00001837073,0.001015087,0.001792504,0.3034296,0.6059729],"study_design_scores_gemma":[0.000277968,0.00003317922,0.0002572423,0.0008822642,0.000294595,0.00001512077,0.00001097007,0.000002905451,0.00004205305,0.00002896594,0.9975573,0.0005973867],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009914383,0.9959965,0.0001563009,0.000007636471,0.0002852363,0.001320419,0.0007606214,0.00004481895,0.0004369863],"genre_scores_gemma":[0.0002416089,0.9950783,0.0001780398,0.00009512709,0.00063973,0.00041884,0.00243108,0.0001144266,0.0008028579],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6941278,"threshold_uncertainty_score":0.9997647,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02500131258589668,"score_gpt":0.3008105274606349,"score_spread":0.2758092148747383,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}